Combined Upper Extremity Resistance and Aerobic Exercise Training in Patients With Breast Cancer
Launched by HACETTEPE UNIVERSITY · Jul 9, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special exercise program might help women who have had breast cancer improve the strength and function of their arms. The program combines two types of exercise: resistance training using elastic bands, which gently work the muscles, and aerobic exercise, which helps improve overall fitness. Researchers want to see if this combination can reduce common problems breast cancer survivors face, like arm weakness, swelling (called lymphedema), muscle loss, and general tiredness, while also improving quality of life.
Women between 18 and 80 years old who had breast cancer surgery at least 15 months ago and are not currently active in regular exercise might be eligible to join. Participants should be able to understand and follow instructions and not have other health issues that could affect their arms or ability to exercise safely. If selected, they will take part in guided exercise sessions focused on improving arm strength and fitness, which could help them feel stronger and more capable in daily activities. This study is still looking for volunteers, and it hopes to find better ways to support breast cancer survivors in regaining arm function and overall well-being.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • To be between 18-80 years old,
- • Volunteering to participate in the research,
- • At least 15 months after breast cancer surgery,
- • No problems in reading and/or understanding the scales and being able to co-operate with the tests.
- • Physically inactive (60 minutes of structured exercise per week \<).
- Exclusion Criteria:
- • Presence of active infection,
- • Presence of bilateral breast cancer,
- • History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery,
- • Having a neurological disease or other clinical diagnosis that may affect cognitive status,
- • Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease.
- • Presence of unstable hypertension or diabetes mellitus.
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, State, Turkey
Patients applied
Trial Officials
Melda Saglam, PhD
Study Chair
Hacettepe University, Ankara, Turkey
Ebru Calik Kutukcu, PhD
Principal Investigator
Hacettepe University, Ankara, Turkey
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported